BNBionano Genomics, Inc. BNGO · NASDAQ
$1.22 +5.17% (+$0.06)
- Market cap
- $14.4M
- Enterprise value
- $17.3M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -83.9%
- Gross margin
- 47.5%
- Net margin
- -106.6%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.66
- Free float
- 90.3%
About the company
Bionano Genomics (BNGO) is a biotechnology company focused on developing and commercializing its advanced genomic platform. This platform enables the study of the structure and variations of the human genome with high accuracy and detail. Bionano Genomics aims to provide tools for genetic research, genetic disease diagnostics, and personalized medicine. Bionano Genomics stock is suitable for investors interested in the biotechnology sector and innovative technologies in the field of genetics. Add Bionano Genomics stock to your watchlist on Bulios and stay informed about the latest advancements in genomics and biotechnology.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert A. Luderer
Employees
96
Headquarters
San Diego
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue growth is slowing: 0.8% a year over the last 3 years against 27% over 5 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number